Diagram is your expert in supporting cardiovascular research. Every clinical scientific research project is unique and deserves a customized approach! Schedule your appointment in advance and contact us!
The final one and two year results of the REDUCE trial have been presented as Late Breaking Trial by prof. Giuseppe De Luca at the EuroPCR congres in Paris.
According to the results of the DAPA trial, prophylactic implantation of an implantable cardioverter defibrillator within 90 days in patients with STEMI undergoing PCI reduced the risk for death in certain high-risk patients.
Recently, the audit took place at Diagram for the recertification of our ISO 9001:2015 quality management system. We are proud to announce that our ISO certificate has been extended until September 22, 2021.
